Stock Markets April 7, 2026

After-hours movers: Levi, Skillsoft climb; Greenbrier, Aehr Test and Insmed retreat

Evening trading reacts to quarterly results and program updates across retail, biotech, test-equipment, software and rail names

By Nina Shah LEVI INSM AEHR SKIL GBX
After-hours movers: Levi, Skillsoft climb; Greenbrier, Aehr Test and Insmed retreat
LEVI INSM AEHR SKIL GBX

Stocks moved in after-hours trading as company-specific news drove share-price reactions. Levi reported stronger-than-expected quarterly revenue, Skillsoft rallied despite year-over-year revenue that was slightly lower, while Greenbrier, Aehr Test Systems and Insmed saw declines after misses, guidance adjustments, or clinical setbacks.

Key Points

  • Levi reported Net Revenues of $1.7 billion, up 14% reported and 9% organic versus Q1 2025; its stock rose about 6% in after-hours trading.
  • Skillsoft rallied roughly 25% after reporting Total Revenue of $131 million compared with $134 million a year earlier.
  • Greenbrier missed earnings estimates, cut its fiscal 2026 production ramp-up timing, and expects double digit lease-fleet growth in fiscal 2026; the stock fell about 5%.

Shares in several publicly traded companies shifted in after-hours trading following earnings results and program updates. Market reactions were stock-specific, reflecting quarterly performance, guidance revisions and clinical trial outcomes.


Levi (LEVI) climbed about 6% after reporting quarterly results that showed Net Revenues of $1.7 billion. Management said revenues rose 14% on a reported basis and 9% on an organic basis versus Q1 2025.

Insmed (INSM) declined roughly 2% after the company announced it was discontinuing its hidradenitis suppurativa program following a failed trial.

Aehr Test Systems (AEHR) slid approximately 3% when third-quarter revenue came in below consensus. The company reported revenue of $10.3 million for the quarter versus the consensus estimate of $10.8 million.

Skillsoft (SKIL) jumped about 25% after reporting quarterly figures that market participants interpreted positively. The company reported Total Revenue of $131 million compared with $134 million in the prior year.

Greenbrier Cos. (GBX) fell about 5% after missing estimates on both the top line and the bottom line. Greenbrier also revised its fiscal 2026 guidance to reflect a more gradual production ramp-up, citing a shift of deliveries into early fiscal 2027. The company said this timing change is driven by order timing rather than changes to underlying demand. The updated outlook also incorporates increased investment in the lease fleet, with Greenbrier expecting double digit fleet growth in fiscal 2026 to expand recurring revenue.


The after-hours moves in these names illustrate how corporate announcements - from trial outcomes to delivery scheduling and capital allocation toward leasing fleets - can produce divergent price responses outside regular market hours. Revenues, guidance changes and program terminations were the primary drivers of the moves reported here.

Market participants considering Aehr Test Systems' outlook may question valuation following the revenue miss. Some investors and analysts look to valuation tools and model mixes to assess whether a name presents upside after a shortfall; the presence of a revenue shortfall at Aehr has prompted such valuation inquiries in the market.


Sectors impacted - The moves touched multiple sectors: apparel retail for Levi, biotechnology for Insmed, semiconductor test equipment for Aehr Test Systems, education and corporate learning software for Skillsoft, and rail manufacturing and leasing for Greenbrier.

Trading context - These price changes occurred in after-hours trading sessions and reflect investor responses to company-released information rather than macro market news.

Risks

  • Clinical program discontinuation - Insmed's decision to terminate its hidradenitis suppurativa program following a failed trial creates development risk for the biotech sector.
  • Revenue shortfalls and missed estimates - Aehr Test Systems' Q3 revenue missing consensus underscores execution and demand risk within the semiconductor test-equipment sector.
  • Guidance and delivery timing changes - Greenbrier's updated fiscal 2026 guidance and shifted deliveries into early fiscal 2027 introduce timing risk for revenue recognition in the rail manufacturing and leasing sector.

More from Stock Markets

Mexican equities slip on sector weaknesses; S&P/BMV IPC down 0.66% Apr 7, 2026 Moscow Stocks Finish Higher as Energy, Power and Manufacturing Names Lead Gains Apr 7, 2026 Colombian Stocks Slip; COLCAP Ends Down 1.06% as Financials and Utilities Weigh Apr 7, 2026 Super Micro Initiates Independent Probe After Indictments Tied to Export-Control Allegations Apr 7, 2026 Insmed Halts Hidradenitis Suppurativa Program After Phase 2b Misses Endpoints Apr 7, 2026